| Tag | Content |
|---|
EnhancerAtlas ID | HS062-14067 |
Organism | Homo sapiens |
Tissue/cell | GM18486 |
Coordinate | chr6:42011320-42013250 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr6:42012125-42012144 | CAGCTCCACCTGGTGGACG | - | 6.87 | | NR2C2 | MA0504.1 | chr6:42012457-42012472 | TGACCTCTCACCTCC | - | 6.93 | | POU4F2 | MA0683.1 | chr6:42013163-42013179 | ATAAATATTAAATGAG | + | 6.14 |
|
| | Number of super-enhancer constituents: 25 | ID | Coordinate | Tissue/cell |
| SE_11383 | chr6:42005515-42019481 | CD20 | | SE_14666 | chr6:42011375-42020084 | CD4_Memory_Primary_7pool | | SE_17523 | chr6:42005090-42012645 | CD4p_CD25-_CD45RAp_Naive | | SE_17523 | chr6:42012658-42020212 | CD4p_CD25-_CD45RAp_Naive | | SE_18157 | chr6:42005987-42019945 | CD4p_CD25-_CD45ROp_Memory | | SE_19395 | chr6:42011198-42012568 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_19395 | chr6:42012688-42019584 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_21138 | chr6:42012633-42017011 | CD8_Memory_7pool | | SE_22115 | chr6:42008515-42012587 | CD8_Naive_8pool | | SE_22115 | chr6:42012596-42019478 | CD8_Naive_8pool | | SE_22982 | chr6:42011272-42019547 | CD8_primiary | | SE_25358 | chr6:42005128-42012573 | DND41 | | SE_25358 | chr6:42012669-42019577 | DND41 | | SE_31011 | chr6:42011216-42012582 | Fetal_Thymus | | SE_31011 | chr6:42012670-42019507 | Fetal_Thymus | | SE_39507 | chr6:42011390-42012112 | Jurkat | | SE_43278 | chr6:42011155-42012527 | Lung | | SE_43278 | chr6:42012647-42016912 | Lung | | SE_49894 | chr6:42010291-42012531 | RPMI-8402 | | SE_53990 | chr6:42011512-42019087 | Spleen | | SE_55251 | chr6:42011342-42012493 | Thymus | | SE_55251 | chr6:42012598-42016845 | Thymus | | SE_60542 | chr6:41974566-42019419 | DHL6 | | SE_62471 | chr6:41974669-42019589 | Tonsil | | SE_66391 | chr6:42011390-42012112 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AGCTACTCAG GAGGCTGAGA TGGGGAGATC AACTCTGCCT GGGAAGTCGA GGCTGCAGTG 60
AGCCGAGATC ACGCCACTGC ACTCCAGCCT GGGCGACAGA GTGAGACCCT GTCTCAAAAA 120
AATCAGGGTG TCCTTGCTCA TTCTGGGCTC TGCCTCTGTG TCCCTGGAGG CCCAGTGGCT 180
CTGTGCCTCT CTAAAGGTCT GAGGGGGCAG CAAGCAGATC TGGGCCAACG ACGGAGGTAC 240
CAGCAACCGT CTCCTTCCAG AGATAACCCC TCAGCCCTCA CCTCAGGAAC GACTGTCCTG 300
GGGAATTTCA CCCAGGGTGG GAGAACTGGT CAGGCCACTG AGTGCAAATA GTTTCAGAGA 360
GGTGGGGCTC CTGAGGCCCC TTCCGGGAGA TGACACAGGT GTCATGCCCT CTGAAGGGCA 420
TAAAAGGCCA TGCCACATTA GCTACCCTGC TGGCTCGCAG GGCCGTCGGT CCTGCCCTCT 480
GCTCTGGGCA CACGGGTCCC TCTCTCTCAA AGGGAAAGGA CAGTCAGGAA GGGGAAAGAG 540
AAGATGTGGA AGAAATCCCT GACCTGGGGA CGGGTGTATG CCGCAGAGGC GGAGGCCTGC 600
ACGTTCTGGC CGGAGCCTGG ACAAGACAGA AGAGCACCTT TTACGGGGGC TTTGCTGGAT 660
CAAAAGCAGT TCTCTGGGCC CCGGTGTGTA AACAGCTGGT GATGGGCTGG GAGCAGAGGC 720
TCCCTGAAAC CAGTCAGCGC CTGAAGAACC CGGCAACACT CTTCATTCAC CCAATCCAGT 780
CACCCCAAGG TGACACACGG GGCAACAGCT CCACCTGGTG GACGATCAGG GACTACCACG 840
GGCCAGGGAG TATGGGAGAG CAAAGAATGA CATAGAAGAG GAAAGCAGGG GGAAAATCAC 900
ATCAGGGGTT TACAGGCGAA GGGGCTTTGA GGTCGTCTTG CTGGCAGAGG CCCCTCTTAT 960
AGCATGAGCT CTAAGCCCCA TTTGTTAGAA AGTTCTACGT TTTTTGAAAA TCTGCCTCCA 1020
CTAGTCCCAC TAACCCCCTA CTTCAAGGTT TGCCAGGGCA AACTTTTAAA TATTTGCATA 1080
CAGCTATAGT ATTCCTCCTA AATCTTCCCC TTTGCTGCAA TCTTCCAGAA TTTGACCTGA 1140
CCTCTCACCT CCTGCATCTT TTTTTAACTT GGCTATCTTT TCTTTCTTTT CTTTCTTTCC 1200
TTTTATTTAT TTATTTATTT ATTTGAGACG GAGTCTCACT CTGTTGCCCA GGCTGGAGTG 1260
CGATGGCGTG ATCTTGGCTC ACTGCAACCT CCGCCTCCCG GGTTCAAGTG ATTCTCCCAC 1320
CTCAGCCTCC TGAGTAGGTG GGATTACAGG CCCGTGCGAC CACGCCCGGC TAACGTTTTT 1380
TTTTTTTTTT TTTTTGTATT TTTAGTAGAG ATGAGGTTTC ACCATGTTGG TCAGGCTGGT 1440
CTCGAACTGC TGACCTCGTG ATCCGCCCAC CTTGGCCTCC CAAAGTGCTG GGATTACAGG 1500
CGTGAGCCAC TGTGCCCAGT GGCTATCCTT TCTTAAATAC ATTAACTTCC AAGGAATCCC 1560
TTCCAATTCT ATCCCTCTCC CATACTAGCA GCAGCATTTA AAAAAATCCC TTTATATTTC 1620
AGCCTCCCTG TCTCAGTGTT TGATATATTA GGAAAGTCAA TGCTCAGACT GAGAGTTAAT 1680
TCACGAGTAA AGAGCCTAGA CTTTGAAATC AGATAGATCC TCGTTCAATT CCAAGCTCTG 1740
CCACTTACTA GCTAAATTAC TTTGAGCAAG TTTGCCTTTC TGAGCCTCAG TTTCCTATCT 1800
GTAAATTGGA GATAGAGGTG TTTACTACCT AGAGTTGTGG TGAATAAATA TTAAATGAGA 1860
CAGTACAAGT AAAAACTTAG GGACAGCTCC CGCAACACCA TTCAGCTCCT AAGTGGCAAT 1920
TACAGCCACA 1930
|
